# Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

> **NCT06984536** · PHASE2 · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Myelodysplastic Syndrome
- Acute Leukemia

## Interventions

- **DRUG:** Reduced ATG plus mini PTCy

## Key facts

- **NCT ID:** NCT06984536
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-21
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06984536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06984536, "Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06984536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*